109 related articles for article (PubMed ID: 8148801)
1. Relationship between the tissue distribution and antitumor activity of highly branched (1-->3)-beta-D-glucan, SSG.
Suda M; Ohno N; Adachi Y; Yadomae T
Biol Pharm Bull; 1994 Jan; 17(1):131-5. PubMed ID: 8148801
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
Suda M; Ohno N; Adachi Y; Yadomae T
J Pharmacobiodyn; 1992 Aug; 15(8):417-26. PubMed ID: 1479542
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
Ohno N; Kurachi K; Yadomae T
J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the antitumor effect and tissue distribution of highly branched (1-->3)-beta-D-glucan, SSG, by carrageenan.
Suda M; Ohno N; Adachi Y; Yadomae T
Biol Pharm Bull; 1995 May; 18(5):772-5. PubMed ID: 7492998
[TBL] [Abstract][Full Text] [Related]
5. Effect of intraperitoneally administered beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages.
Sakurai T; Suzuki I; Kinoshita A; Oikawa S; Masuda A; Ohsawa M; Yadomae T
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):214-7. PubMed ID: 2049804
[TBL] [Abstract][Full Text] [Related]
6. The effects of a highly branched beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice.
Suzuki I; Hashimoto K; Yadomae T
J Pharmacobiodyn; 1988 Aug; 11(8):527-32. PubMed ID: 3236210
[TBL] [Abstract][Full Text] [Related]
7. Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1----3)-beta-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
Kurachi K; Ohno N; Yadomae T
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2527-31. PubMed ID: 2285987
[TBL] [Abstract][Full Text] [Related]
8. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.
Sakurai T; Ohno N; Suzuki I; Yadomae T
Immunopharmacology; 1995 Aug; 30(2):157-66. PubMed ID: 8530257
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of hematopoietic response of mice by intraperitoneal administration of a beta-glucan, SSG, obtained from Sclerotinia sclerotiorum.
Hashimoto K; Suzuki I; Ohsawa M; Oikawa S; Yadomae T
J Pharmacobiodyn; 1990 Aug; 13(8):512-7. PubMed ID: 2079647
[TBL] [Abstract][Full Text] [Related]
10. Alteration of beta-D-glucan from edible mushroom after injection into mouse peritoneal cavity.
Sone Y; Shibata S; Kishida E; Misaki A
J Nutr Sci Vitaminol (Tokyo); 1994 Aug; 40(4):335-41. PubMed ID: 7844640
[TBL] [Abstract][Full Text] [Related]
11. Metabolic 13C-labeling of an antitumor (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
Suda M; Ohno N; Adachi Y; Yadomae T
Biosci Biotechnol Biochem; 1995 Feb; 59(2):203-7. PubMed ID: 7766018
[TBL] [Abstract][Full Text] [Related]
12. Preparation and properties of metabolically 3H- or 13C-labeled (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
Suda M; Ohno N; Adachi Y; Yadomae T
Carbohydr Res; 1994 Feb; 254():213-9. PubMed ID: 8180985
[TBL] [Abstract][Full Text] [Related]
13. Distribution of grifolan NMF-5N (I/B), a chemically modified antitumor beta-glucan in mice.
Takeyama T; Suzuki I; Ohno N; Oikawa S; Sato K; Ohsawa M; Yadomae T
J Pharmacobiodyn; 1988 Jun; 11(6):381-5. PubMed ID: 3171879
[TBL] [Abstract][Full Text] [Related]
14. Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice.
Suda M; Ohno N; Hashimoto T; Koizumi K; Adachi Y; Yadomae T
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):93-100. PubMed ID: 8880133
[TBL] [Abstract][Full Text] [Related]
15. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.
Sakurai T; Kaise T; Yadomae T; Matsubara C
Eur J Pharmacol; 1997 Sep; 334(2-3):255-63. PubMed ID: 9369356
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by orally administered beta-glucan in mice.
Suzuki I; Hashimoto K; Ohno N; Tanaka H; Yadomae T
Int J Immunopharmacol; 1989; 11(7):761-9. PubMed ID: 2599714
[TBL] [Abstract][Full Text] [Related]
17. Intravenously administered (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 augments murine peritoneal macrophage functions in vivo.
Sakurai T; Ohno N; Yadomae T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2120-4. PubMed ID: 1423766
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of (1-->3)-beta-D-glucan in mice.
Miura T; Ohno N; Suda M; Miura NN; Shimada S; Yadomae T
Biol Pharm Bull; 1995 Dec; 18(12):1797-1801. PubMed ID: 8787813
[TBL] [Abstract][Full Text] [Related]
19. Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice.
Miura NN; Ohno N; Aketagawa J; Tamura H; Tanaka S; Yadomae T
FEMS Immunol Med Microbiol; 1996 Jan; 13(1):51-57. PubMed ID: 8821398
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of murine alveolar macrophage functions by orally administered beta-glucan.
Sakurai T; Hashimoto K; Suzuki I; Ohno N; Oikawa S; Masuda A; Yadomae T
Int J Immunopharmacol; 1992 Jul; 14(5):821-30. PubMed ID: 1512075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
